Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

OGS and Pfizer to collaborate on Alzheimer's disease research

April 17, 1998

Ampligen to be evaluated in U.S. phase III trials for chronic fatigue syndrome

April 17, 1998

Novel dopaminergic compounds in the pipeline at ADIR

April 17, 1998

Another H3 antagonist in the pipeline at Gliatech

April 16, 1998

DuPont Merck presents a novel CRF-R1 antagonist for anxiety and depression

April 16, 1998

Meiji Seika presents 5-HT7 antagonist DR-4004

April 16, 1998

Kynurenine 3-monooxygenase inhibitors under study at P&U as neuroprotectants

April 16, 1998

Nortran's anesthetic RSD-921 nears phase II trials in Malaysia

April 16, 1998

NeuroSearch receives FDA approval to begin phase II trial with NS-2710

April 16, 1998

CRF antagonists for stress-related disorders from DuPont Merck

April 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...